ClinicalTrials.Veeva

Menu

The Characteristics of Backscattering With Depth in the Progression of Keratoconus

T

Tianjin Eye Hospital

Status

Completed

Conditions

Elasticum, Incomplete Pseudoxanthoma

Study type

Observational

Funder types

Other

Identifiers

NCT06050629
KY-2023020

Details and patient eligibility

About

To investigate the variation in backscattering with depth between forme fruste keratoconus (FFKC), keratoconus, and normal eyes; to determine the backscattering changes in the characteristics of keratoconus progression; and to explore the diagnostic value of backscattering in FFKC.

Full description

To investigate the variation in backscattering with depth between forme fruste keratoconus (FFKC), keratoconus, and normal eyes; to determine the backscattering changes in the characteristics of keratoconus progression; and to explore the diagnostic value of backscattering in FFKC. A Scheimpflug corneal tomography image and caliper tool were used to obtain backscatter at every 2% depth at the thinnest point of the cornea, with the measured values expressed in grayscale units (GSU).

Enrollment

223 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. BCVA <20/20 and a history of myopia or astigmatism;
  2. presence of any of the following positive signs on slit lamp examination: corneal stromal thinning, cone-shaped anterior protrusions, Fleischer's ring, Vogt's striae, epithelial or subepithelial scarring;
  3. abnormal corneal topography (maximum keratometry (K) value of >47.2 diopters (D), bow-tie pattern with skewed radial axes, or inferior-superior asymmetry(3-mm I-S keratometric difference >1.4 D).

Exclusion criteria

  1. Patients with severe corneal scarring that affected light scattering and density maps showing "black holes" 2.Participatients with other corneal diseases 3. Eyes that have undergone surgery or trauma 4. Eyes with corneal dystrophy

Trial design

223 participants in 4 patient groups

forme fruste keratoconus
Description:
1) no other eye abnormalities except myopia and astigmatism; 2) transparent cornea; 3) no positive signs of keratoconus on slit lamp examination or morphology examination (excluding the appearance of keratoconus as described above, and simultaneously satisfying A0B0C0D0, Index of Surface variance (ISV) \< 30, and Keratoconus Index (KI) \< 1.07); and 4) Belin/Ambrósio enhanced ectasia total derivation value(BAD-D)≤1.6
Clinical keratoconus
Description:
46.5 D ≤ Mean K \<52 D; 55≤ ISV\<200; and 1.10 ≤ KI \<1.50
severe keratoconus
Description:
Mean K ≥ 52D; ISV≥ 200; and KI≥ 1.50
normal eye
Description:
one eye of healthy participants before refractive surgery were randomly selected. Comprehensive ophthalmic examinations were performed before surgery, which confirmed that the cornea was clear and normal in shape. For this group, there was no family history of keratoconus, no other diseases except ametropia, and no corneal dilatation one year after surgery.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems